Manuel Jonathan Fragoso-Vázquez

Deciphering the GPER/GPR30-agonist and antagonists interactions using molecular modeling studies, molecular dynamics, and docking simulations

David Méndez-Luna, Marlet Martínez‐Archundia, Rachid C. Maroun et al. · Journal of Biomolecular Structure and Dynamics · 2015 · 74 citations

Medicine, Molecular Biology, Pharmacology +17

Neuroprotective Effects of Apocynin and Galantamine During the Chronic Administration of Scopolamine in an Alzheimer’s Disease Model

Eliezer Joseph, Daniel Miguel Ángel Villalobos-Acosta, Mónica Torres-Ramos et al. · Journal of Molecular Neuroscience · 2019 · 43 citations

Medicine, Neuroscience, Pharmacology +17

N-(2-hydroxyphenyl)-2-propylpentanamide, a valproic acid aryl derivative designed <i>in silico</i> with improved anti-proliferative activity in HeLa, rhabdomyosarcoma and breast cancer cells

Berenice Prestegui-Martel, Jorge Antonio Bermúdez-Lugo, Alma Chávez‐Blanco et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2016 · 42 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

In silico search, chemical characterization and immunogenic evaluation of amino-terminated G4-PAMAM-HIV peptide complexes using three-dimensional models of the HIV-1 gp120 protein

Rolando Alberto Rodríguez-Fonseca, Martiniano Bello, María Ángeles de los Muñoz-Fernández et al. · Colloids and Surfaces B Biointerfaces · 2019 · 27 citations

Life Sciences, Immunology, Molecular Biology +17

<i>N</i>-(2′-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells

Arturo Contis‐Montes de, Estefanía Rodarte-Valle, Martha Cecilia Rosales‐Hernández et al. · Oncotarget · 2018 · 19 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +7